<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="to a lack of published studies in Latin and Central" exact="America" post="and the Caribbean. Our Ovid MEDLINE search is shown"/>
 <result pre="studies also used data from partnering high-income countries, including Canada," exact="Australia" post="and the United States. We observed an inverse association"/>
 <result pre="used data from partnering high-income countries, including Canada, Australia and" exact="the United States." post="We observed an inverse association between HCV infection rates"/>
 <result pre="data from partnering high-income countries, including Canada, Australia and the" exact="United States." post="We observed an inverse association between HCV infection rates"/>
 <result pre="who completed DAA treatment; they identified studies conducted in Demark," exact="Spain" post="and the USA with high reinfection rates ranging from"/>
 <result pre="DAA treatment; they identified studies conducted in Demark, Spain and" exact="the USA" post="with high reinfection rates ranging from 8.0 to 18.3"/>
 <result pre="from 1.1 to 1.7 cases per 100 PY in Canada," exact="the USA" post="and Germany [16]. Notably, the USA study results are"/>
 <result pre="1.7 cases per 100 PY in Canada, the USA and" exact="Germany" post="[16]. Notably, the USA study results are in both"/>
 <result pre="100 PY in Canada, the USA and Germany [16]. Notably," exact="the USA" post="study results are in both the low and high"/>
 <result pre="weeks 0.01 2 Huang et al., 2019 [21] Cohort study" exact="Taiwan" post="= $14,273Upper middle-income N = 219Male 100.0%Prevalence = 33.7%"/>
 <result pre="years 0.02 4 Rahman et al., 2019 [23] Prospective cohort" exact="Bangladesh" post="= $1698Lower middle-income N = 200Sex not delineatedPrevalence ="/>
</results>
